31 studies found for:
" July 23, 2008":" August 22, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.
|
||||
| 2 |
Completed
Has Results |
Safety and Efficacy Study of Switching From Epzicom to Truvada
|
||||
| 3 | Completed |
Effectiveness of Armodafinil for Treating Fatigue in Adults With HIV/AIDS
|
||||
| 4 |
Completed
Has Results |
Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)
|
||||
| 5 | Unknown † |
Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects
|
||||
| 6 |
Completed
Has Results |
Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure
|
||||
| 7 | Active, not recruiting |
Bone Mineral Density Substudy - An Ancillary Study to MTN-003
|
||||
| 8 | Completed |
Genetic Determinants of the Metabolism of Non-nucleoside Reverse Transcriptase Inhibitors
|
||||
| 9 | Completed |
Genetic Predictors of Raltegravir Penetration Into Cerebrospinal Fluid
|
||||
| 10 | Completed |
Family Centered Advanced Care Planning for Adolescents With HIV/AIDS and Their Families
|
||||
| 11 | Completed |
Surveillance and Medical Help for HIV-infected Intravenous Drug Users in and Out of Prison
|
||||
| 12 | Completed |
The Effect of Vitamin D and Calcium on Bone in Pediatric HIV
|
||||
| 13 | Unknown † |
Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment
|
||||
| 14 | Completed |
GSK706769/KALETRA Drug-drug Interaction Study
|
||||
| 15 | Completed |
Maraviroc 300 mg Twice Daily in HIV Negative Male Volunteers
|
||||
| 16 |
Completed
Has Results |
Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing.
|
||||
| 17 | Completed |
Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 Infection
|
||||
| 18 | Completed |
Assess the Downregulation of HIV-1 When Raltegravir is Added to a Virologically Suppressed HAART Regimen
|
||||
| 19 | Completed |
A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT
|
||||
| 20 | Terminated |
Combination of an Investigational Cannabinoid and Methadone for HIV-associated Neuropathy
|
† Indicates status has not been verified in more than two years
